GSK Plc

Posted on November 14, 2016 by Nairametrics

CEO of Suntory Ltd,  Makes First Comment Since Buying Ribena and Lucozade

Suntory Beverage and Food Nigeria recently acquired the distribution business of popular beverage brands, Lucozade and Ribena from GSK Nigeria. The Managing Director of Suntory Beverage & Food Nigeria, Chinedum Okereke, recently spoke to the media for the first time since the acquisition. These are excerpts of his speech: “This is a clear demonstration of Read More

Posted on October 28, 2016 by mudeerat olawunmi

ALERT: GlaxoSmithKline Nigeria Plc Release 2016 Third Quarter Earnings

GSK Nigeria Plc released its 2016 result for the nine months ended 30 September 2016 ; See below     GlaxoSmithKline Nigeria Plc2016 Quarter Three Results GSK Nigeria  Plc 2016 Q3 2015 Q3 %age Change N’000 N’000 Revenue  20,540,327        23,040,004 -11% Pre-tax (loss)/profits (6,288,241)             700,959 (loss)/Profit after tax  (4,046,403)             485,942 EPS (Kobo)   Read More

Posted on October 5, 2016 by Nairametrics

GSK Nigeria Completes Divestment of Drinks Bottling Business To Suntory BFN Ltd.

Glaxosmithkline Consumer Nigeria Plc has completed the divestment of its drinks bottling and distribution business to Suntory Beverage & Food Nigeria Limited (SBFN). The company said the completion of the divestment followed approvals from the shareholders and the Nigeria Securities & Exchange Commission (SEC). Following this approval, GSK has transferred ownership of the drinks business Read More

Posted on July 27, 2016 by mudeerat olawunmi

GSK Declares 60 Kobo Special Dividend to Shareholders

GlaxoSmithKline Consumer Goods Nigeria Plc has announced the declaration of a special dividend of 60 Kobo per share to shareholders. The special dividend was approved by the company’s shareholders during the extra-ordinary general meeting held on Monday, July 4, 2016 on the disposal of the company’s drinks business (Lucozade and Ribena brands) to Suntory Beverage Read More

Posted on July 5, 2016 by Nairametrics

We Listened In On GSK Investor Conference Call And Here Is What We Discovered

GlaxoSmithKline Consumer Nigeria Plc (GSK) held an investor conference call yesterday to discuss the proposed disposal of its drinks business to Suntory Beverage & Food Nigeria Ltd (Suntory). Finance costs are expected to subside following settlement of huge intercompany payables which had hitherto limited earnings growth due to foreign exchange scarcity and devaluation. GSK Nigeria Read More

Posted on June 2, 2016 by Nairametrics

GSK Nigeria Has Moved One Step Closer Towards Spinning Off Ribena & Lucozade Boost

GlaxoSmithKline Consumer Nigeria Plc has announced that its Board of Directors have approved the binding offer to sell its drinks bottling and distribution business to Suntory Beverage & Food Nigeria Ltd. The company has now recommended that its shareholders approve the offer This announcement takes the company one step closer towards spinning off division that Read More

Posted on March 16, 2016 by Jon Snow

GSK Gets Squeezed By Economic Doldrums As Earnings Slump

GlaxoSmithKline Consumer Nigeria Plc, the publicly traded local unit of the U.K.’s biggest drug maker has been hard squeezed by a challenging business environment as the company’s earnings slumped. The 2015 audited financial statement of the company showed net income fell by 48.28 percent to N954.5 million from N1.84 billion as at December 2014. Sales Read More

Posted on March 16, 2016 by Olarinmoye Segun

GlaxoSmithkline Pre-tax Profit Down 57% To N1.1 billion, Proposes Dividend of 30 Kobo

Glaxosmithkline released its financial results for the year ended 31st December 2015. The results showed that revenue increased marginally by 0.37% from N30.5 billion in 2014 to N30.6 billion in 2015, while gross profit declined by 4.4% from N10.8 billion to N10.3 billion in 2015. Pre-tax profits declined by 57% from N2.7 billion in 2014 Read More

Posted on February 19, 2016 by Rencap

“Extranormal” : Rencap Explains Why GSK Nigeria Is A Strong Buy

On 25 January 2016, GlaxoSmithKline Consumer Nigeria Plc (GSK Nigeria) received a non-binding offer from Suntory Beverages & Foods Ltd (Suntory) to acquire GSK Nigeria’s drinks business. Although we are cautious on Nigeria – the consumer environment remains challenging as disposable income dwindles and operating costs escalate – we believe the deal could benefit shareholders Read More

Posted on January 28, 2016 by Nairametrics

GSK Nigeria Has Received An Offer To Sell Its Ribena & Lucozade Businesses

Reuters reports GSK has been made an offer to sell its bottling and distribution drinks businesses. The offer to divest came from Suntory Beverage & Food Ltd. If transaction is agreed and approved, GSK Nigeria would only now own its wellness, oral healthcare business nutrition and pharmaceutical businesses. GSK Nigeria’s bottling franchise includes Ribena and Lucozade Boost and Read More

Posted on October 28, 2015 by Editor

[Corporate Action] GlaxoSmithKline’s Profits Drops By 74% to N485 million In Q3’2015

GlaxoSmithKline Nigeria Plc released its financial results for nine months ended September 2015. The result showed that revenue declined by 24.51% from N30.5 billion in Q3’2014 to N23 billion in Q3’2015. Profit before tax also declined by 74.51% from N2.7 billion in Q3’2014 to N700 million in Q3’2015. See Summary of result below.. GlaxoSmithkline Nigeria Read More

Posted on September 7, 2015 by Renaissance Capital

Here Is Why Renaissance Capital Switched GSK & 7up to a BUY

We assess the bottom of the pyramid (BOP) consumer in Nigeria and analyse which companies both private and public play this segment of the population. We provide a cross comparison of consumer names and the sector across frontier markets. We also provide results of our consumer survey and launch a CPI tracker for Nigeria. Based Read More

Posted on August 11, 2015 by JON SNOW

Nigeria Drug makers capitulate as margins slump

Drug makers in Africa largest economy have capitulated to huge production costs that left these companies with low profit margins. This also affected the returns to shareholders. The companies under our analysis are: GlaxoSmithKline Nigeria Plc, Fidson Nigeria Plc, May and Baker Nigeria Plc and PharmaDeko Nigeria Plc. The cumulative net income of the four Read More

Posted on August 1, 2015 by Nairametrics

[YEAR LOW] These 7 Blue Chip Nigerian Stocks Just Got Bloodied

This week ended with yet another sell-off as stocks shed a whopping N900 billion in one week. A major reason for the decline were some Blue Chip Nigerian companies contributing in dragging the index back by about 2.9%. Amongst this park were 7 Blue Chip stocks that cut across the banking, pharmaceutical, FMCG and Upstream sector. This basically Read More

Posted on July 24, 2014 by Nairametrics

BIG DEAL: GSK Seeks Approval For Worlds First Malaria Vaccine

  GlaxoSmithKline said on Thursday it is applying for regulatory approval for the world’s first vaccine against malaria, designed for children in Africa. The British drugmaker said the shot, called RTS,S, is intended exclusively for use outside the European Union but will be evaluated by the European Medicines Agency (EMA) in collaboration with the World Read More

Older Posts